Intravitreal Bevacizumab for Low Vision in Neovascular Age-related Macular Degeneration (AMD)

• Status: Completed
• Trial end date: 2011-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare the effectiveness of intravitreal bevacizumab injection (IVBI) with respect to simple observation in patients with subfoveal choroidal neovascularisation (CNV) secondary to age-related macular degeneration (AMD) presenting at baseline with best corrected visual acuity (BCVA) less than 20/200.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: IRCCS San Raffaele
• Treatments: Bevacizumab

Criteria

Inclusion Criteria:

• age-related macular degeneration

• naïve subfoveal choroidal neovascularization

• best-corrected visual acuity less then 20/200

Exclusion Criteria:

• previous treatments

• any other condition able to limit the visual improvement